USP6 and chronic myelogenous leukemia, BCR-ABL1 positive: The USP6 mRNA level was further measured in the samples of Cohort 2, and the qPCR results demonstrated that USP6 was significantly upregulated in patients with CML compared with that of normal controls (Fig. 1E).